Literature DB >> 22713148

Prorenin receptor regulates more than the renin-angiotensin system.

Dominik N Müller1, Katrina J Binger, Fabian Riediger.   

Abstract

The (pro)renin receptor (PRR) was initially believed to be a contributor to the pathogenesis of cardiovascular diseases via the amplification of renin- or prorenin-induced angiotensin (Ang) formation. However, a recent paradigm shift suggests a new role for PRR, separate from the renin-angiotensin system (RAS), in contributing to cellular homeostasis. Specifically, PRR is thought to be essential for vacuolar H(+) -ATPase (V-ATPase) activity and acts as an adaptor between the V-ATPase and the Wnt signalling pathway. Recent PRR conditional knock-out studies have confirmed this link between V-ATPase and PRR, with deletion resulting in the accumulation of autophagic vacuoles and animal lethality. The molecular mechanism by which PRR contributes to V-ATPase activity, and whether multiple signalling pathways are affected by PRR loss, is currently unknown. Additionally, cleavage by furin at a single site within full-length PRR results in the production of a soluble form of the receptor, which is detectable in plasma. Soluble PRR is hypothesized to bind to specific ligands and receptors and mediate signal transduction pathways. Understanding the physiological function of full-length and soluble PRR will be important for establishing its role in pathology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22713148     DOI: 10.3109/07853890.2012.660496

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  7 in total

1.  Genetic disruption of guanylyl cyclase/natriuretic peptide receptor-A upregulates renal (pro) renin receptor expression in Npr1 null mutant mice.

Authors:  Ramu Periyasamy; Subhankar Das; Kailash N Pandey
Journal:  Peptides       Date:  2019-04-06       Impact factor: 3.750

2.  Collecting duct prorenin receptor knockout reduces renal function, increases sodium excretion, and mitigates renal responses in ANG II-induced hypertensive mice.

Authors:  Minolfa C Prieto; Virginia Reverte; Mykola Mamenko; Marta Kuczeriszka; Luciana C Veiras; Carla B Rosales; Matthew McLellan; Oliver Gentile; V Behrana Jensen; Atsuhiro Ichihara; Alicia A McDonough; Oleh M Pochynyuk; Alexis A Gonzalez
Journal:  Am J Physiol Renal Physiol       Date:  2017-08-16

3.  Duck Tembusu virus infection induces mitochondrial-mediated and death receptor-mediated apoptosis in duck embryo fibroblasts.

Authors:  Yuhong Pan; Wenjun Cai; Anchun Cheng; Mingshu Wang; Shun Chen; Juan Huang; Qiao Yang; Ying Wu; Di Sun; Sai Mao; Dekang Zhu; Mafeng Liu; Xinxin Zhao; Shaqiu Zhang; Qun Gao; Xumin Ou; Bin Tian; Zhongqiong Yin; Renyong Jia
Journal:  Vet Res       Date:  2022-07-07       Impact factor: 3.829

4.  Adipocyte (Pro)Renin-Receptor Deficiency Induces Lipodystrophy, Liver Steatosis and Increases Blood Pressure in Male Mice.

Authors:  Chia-Hua Wu; Shayan Mohammadmoradi; Joel Thompson; Wen Su; Ming Gong; Genevieve Nguyen; Frédérique Yiannikouris
Journal:  Hypertension       Date:  2016-05-16       Impact factor: 10.190

5.  (Pro)Renin receptor mediates obesity-induced antinatriuresis and elevated blood pressure via upregulation of the renal epithelial sodium channel.

Authors:  Syed S Quadri; Silas Culver; Nrupama Ramkumar; Donald E Kohan; Helmy M Siragy
Journal:  PLoS One       Date:  2018-08-17       Impact factor: 3.240

Review 6.  EXPRESSION OF THE RENIN-ANGIOTENSIN SYSTEM COMPONENTS IN ONCOLOGIC DISEASES.

Authors:  Sergey Dolomatov; Walery Zukow; Nikolay Novikov; Alexandra Markaryan; Elena Eremeeva
Journal:  Acta Clin Croat       Date:  2019-06       Impact factor: 0.780

7.  Association between soluble (Pro)renin receptor concentration in cord blood and small for gestational age birth: a cross-sectional study.

Authors:  Noriyoshi Watanabe; Satoshi Morimoto; Takeo Fujiwara; Tomo Suzuki; Kosuke Taniguchi; Takashi Ando; Tadashi Kimura; Haruhiko Sago; Atsuhiro Ichihara
Journal:  PLoS One       Date:  2013-03-21       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.